Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
38410442
TITLE
Identifying genetic differences between bipolar disorder and major depression through multiple GWAS.
ABSTRACT
BACKGROUND NlmCategory: UNASSIGNED
Accurate diagnosis of bipolar disorder (BD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A key reason is that the first manic episode is often preceded by a depressive one, making it difficult to distinguish BD from unipolar major depressive disorder (MDD).
AIMS NlmCategory: UNASSIGNED
Accurate diagnosis of bipolar disorder (BD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A key reason is that the first manic episode is often preceded by a depressive one, making it difficult to distinguish BD from unipolar major depressive disorder (MDD). Here, we use genome-wide association analyses (GWAS) to identify differential genetic factors and to develop predictors based on polygenic risk scores that may aid early differential diagnosis.
METHODS NlmCategory: UNASSIGNED
Accurate diagnosis of bipolar disorder (BD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A key reason is that the first manic episode is often preceded by a depressive one, making it difficult to distinguish BD from unipolar major depressive disorder (MDD). Here, we use genome-wide association analyses (GWAS) to identify differential genetic factors and to develop predictors based on polygenic risk scores that may aid early differential diagnosis. Based on individual genotypes from case-control cohorts of BD and MDD shared through the Psychiatric Genomics Consortium, we compile case-case-control cohorts, applying a careful merging and quality control procedure. In a resulting cohort of 51,149 individuals (15,532 BD cases, 12,920 MDD cases and 22,697 controls), we perform a variety of GWAS and polygenic risk scores (PRS) analyses.
RESULTS NlmCategory: UNASSIGNED
Accurate diagnosis of bipolar disorder (BD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A key reason is that the first manic episode is often preceded by a depressive one, making it difficult to distinguish BD from unipolar major depressive disorder (MDD). Here, we use genome-wide association analyses (GWAS) to identify differential genetic factors and to develop predictors based on polygenic risk scores that may aid early differential diagnosis. Based on individual genotypes from case-control cohorts of BD and MDD shared through the Psychiatric Genomics Consortium, we compile case-case-control cohorts, applying a careful merging and quality control procedure. In a resulting cohort of 51,149 individuals (15,532 BD cases, 12,920 MDD cases and 22,697 controls), we perform a variety of GWAS and polygenic risk scores (PRS) analyses. While our GWAS is not well-powered to identify genome-wide significant loci, we find significant SNP-heritability and demonstrate the ability of the resulting PRS to distinguish BD from MDD, including BD cases with depressive onset. We replicate our PRS findings, but not signals of individual loci in an independent Danish cohort (iPSYCH 2015 case-cohort study, N=25,966). We observe strong genetic correlation between our case-case GWAS and that of case-control BD.
CONCLUSIONS NlmCategory: UNASSIGNED
Accurate diagnosis of bipolar disorder (BD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A key reason is that the first manic episode is often preceded by a depressive one, making it difficult to distinguish BD from unipolar major depressive disorder (MDD). Here, we use genome-wide association analyses (GWAS) to identify differential genetic factors and to develop predictors based on polygenic risk scores that may aid early differential diagnosis. Based on individual genotypes from case-control cohorts of BD and MDD shared through the Psychiatric Genomics Consortium, we compile case-case-control cohorts, applying a careful merging and quality control procedure. In a resulting cohort of 51,149 individuals (15,532 BD cases, 12,920 MDD cases and 22,697 controls), we perform a variety of GWAS and polygenic risk scores (PRS) analyses. While our GWAS is not well-powered to identify genome-wide significant loci, we find significant SNP-heritability and demonstrate the ability of the resulting PRS to distinguish BD from MDD, including BD cases with depressive onset. We replicate our PRS findings, but not signals of individual loci in an independent Danish cohort (iPSYCH 2015 case-cohort study, N=25,966). We observe strong genetic correlation between our case-case GWAS and that of case-control BD. We find that MDD and BD, including BD with a depressive onset, are genetically distinct. Further, our findings support the hypothesis that Controls - MDD - BD primarily lie on a continuum of genetic risk. Future studies with larger and richer samples will likely yield a better understanding of these findings and enable the development of better genetic predictors distinguishing BD and, importantly, BD with depressive onset from MDD.
DATE PUBLISHED
2024 Jan 30
HISTORY
PUBSTATUS PUBSTATUSDATE
pubmed 2024/02/27 06:44
medline 2024/02/27 06:45
entrez 2024/02/27 03:39
pmc-release 2024/02/26
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Panagiotaropoulou G Panagiotaropoulou Georgia G Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Hellberg KG Hellberg Kajsa-Lotta Georgii KG Institute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital, Copenhagen, Denmark.
Coleman JRI Coleman Jonathan R I JRI NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.
Seok D Seok Darsol D Department of Psychiatry, University of California, Los Angeles, CA, USA.
Kalman J Kalman Janos J Institute for Psychiatric Phenomics and Genomics, Ludwig Maximilian University, Munich, Germany.
Bipolar Disorder Working Group of the Psychiatric Genetics Consortium
Major Depressive Disorder Working Group of the Psychiatric Genetics Consortium
iPSYCH Study Consortium
Mitchell PB Mitchell Philip B PB Discipline of Psychiatry and Mental Health, School of Medicine and Health, University of New South Wales, Sydney, Australia.
Schofield PR Schofield Peter R PR School of Biomedical Sciences, University of New South Wales, Sydney, University of New South Wales, Australia.
Forstner AJ Forstner Andreas J AJ Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany.
Bauer M Bauer Michael M Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
Scott LJ Scott Laura J LJ Department of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Pato CN Pato Carlos N CN Department of Psychiatry, Rutgers University, Rutgers Health, Piscataway, NJ, USA.
Pato MT Pato Michele T MT Department of Psychiatry, Rutgers University, Rutgers Health, Piscataway, NJ, USA.
Li QS Li Qingqin S QS Janssen Research and Development, Neuroscience, Titusville, NJ, USA.
Kirov G Kirov George G Cardiff University, Division of Psychological Medicine and Clinical Neuroscience, Cardiff, UK.
Landén M Landén Mikael M Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Jonsson L Jonsson Lina L Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.
Müller-Myhsok B Müller-Myhsok Bertram B Max Planck Institute of Psychiatry, Munich.
Smoller JW Smoller Jordan W JW Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Binder EB Binder Elisabeth B EB Department Genes and Environment, Max Planck Institute of Psychiatry, Munich.
Brückl TM Brückl Tanja M TM Department Genes and Environment, Max Planck Institute of Psychiatry, Munich.
Czamara D Czamara Darina D Department Genes and Environment, Max Planck Institute of Psychiatry, Munich.
der Auwera SV der Auwera Sandra Van SV Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Grabe HJ Grabe Hans J HJ Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Homuth G Homuth Georg G Interfaculty Institute of Functional Genomics, Department of Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Schmidt CO Schmidt Carsten O CO Institute for Community Medicine, Department of Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Potash JB Potash James B JB Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
DePaulo RJ DePaulo Raymond J RJ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Goes FS Goes Fernando S FS Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
MacKinnon DF MacKinnon Dean F DF Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mondimore FM Mondimore Francis M FM Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Weissman MM Weissman Myrna M MM Division of Translational Epidemiology & Mental Health Equity, New York State Psychiatric Institute, New York, NY, US.
Shi J Shi Jianxin J Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Frye MA Frye Mark A MA Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Biernacka JM Biernacka Joanna M JM Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Reif A Reif Andreas A Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.
Witt SH Witt Stephanie H SH Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Kahn RR Kahn René R RR Department of Psychiatry and Behavioral Health System, Icahn School of Medicine at Mount Sinai, NY, USA.
Boks MM Boks Marco M MM Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
Owen MJ Owen Michael J MJ Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK.
Gordon-Smith K Gordon-Smith Katherine K Psychological Medicine, University of Worcester, Worcester, UK.
Mitchell BL Mitchell Brittany L BL Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Martin NG Martin Nicholas G NG Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Medland SE Medland Sarah E SE Mental Health and Neuroscience, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Jones L Jones Lisa L Psychological Medicine, University of Worcester, Worcester, UK.
Knowles JA Knowles James A JA Department of Genetics, Rutgers University, Piscataway, NJ, US.
Levinson DF Levinson Douglas F DF Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, US.
O'Donovan MC O'Donovan Michael C MC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK.
Lewis CM Lewis Cathryn M CM Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Breen G Breen Gerome G NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.
Werge T Werge Thomas T Section for Geogenetics, GLOBE Institute, Faculty of Health and Medical Sciences, Copenhagen University.
Schork AJ Schork Andrew J AJ Institute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital, Copenhagen, Denmark.
Ophoff R Ophoff Roel R Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Ripke S Ripke Stephan S German Center for Mental Health (DZPG), Site Berlin-Potsdam, Germany.
Loohuis LO Loohuis Loes Olde LO Department of Computational Medicine, University of California Los Angeles, Los Angeles, CA, USA.
INVESTIGATORS
JOURNAL
VOLUME:
ISSUE:
TITLE: medRxiv : the preprint server for health sciences
ISOABBREVIATION: medRxiv
YEAR: 2024
MONTH: Jan
DAY: 30
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN:
ISSNTYPE:
MEDLINE JOURNAL
MEDLINETA: medRxiv
COUNTRY: United States
ISSNLINKING:
NLMUNIQUEID: 101767986
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Preprint
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's